A Trial to Compare the Safety of Once Weekly Dosing of Somapacitan With Daily Norditropin® FlexPro® for 26 Weeks in Previously Human Growth Hormone Treated Adults With Growth Hormone Deficiency

Clinical trial NCT02382939 · COMPLETED

Trial details

NCT number: NCT02382939
Sponsor: Novo Nordisk A/S
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Adult Growth Hormone Deficiency Growth Hormone Disorder

Start date: 2015-02-12
Primary completion: 2016-01-04
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.